Fortress Biotech, Inc. Operating Income
Fortress Biotech, Inc. (FBIO) reported Operating Income of -$10.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- Fortress Biotech, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$10.01M.
- Fortress Biotech, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$7.74M.
- Fortress Biotech, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$4.79M.
- Fortress Biotech, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$6.81M.
- Fortress Biotech, Inc. operating income (loss) for fiscal 2025 was -$70.22M.
- Fortress Biotech, Inc. operating income (loss) for fiscal 2024 was -$110.38M.
- Fortress Biotech, Inc. operating income (loss) for fiscal 2023 was -$142.34M.
- Fortress Biotech, Inc. operating income (loss) for fiscal 2022 was -$203.56M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 63 month | Operating Income (Loss) 66 month | Operating Income (Loss) 69 month | Operating Income (Loss) 72 month | Operating Income (Loss) 75 month | Operating Income (Loss) 78 month | Operating Income (Loss) 81 month | Operating Income (Loss) 84 month | Operating Income (Loss) 87 month | Operating Income (Loss) 90 month | Operating Income (Loss) 93 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.01M 10-Q · filed 2026-08-13 | -$17.74M 10-Q · filed 2026-08-13 | -$22.53M derived: sum of 3 quarters · filed 2026-08-13 | -$29.34M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||||
| 2026-03-31 | -$7.74M 10-Q · filed 2026-05-14 | -$12.53M derived: sum of 2 quarters · filed 2026-05-14 | -$19.34M derived: sum of 3 quarters · filed 2026-05-14 | -$55.81M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||||
| 2025-12-31 | -$4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$11.60M derived: sum of 2 quarters · filed 2026-03-31 | -$48.07M derived: sum of 3 quarters · filed 2026-08-13 | -$70.22M 10-K · filed 2026-03-31 | |||||||||||||||
| 2025-09-30 | -$6.81M 10-Q · filed 2025-11-14 | -$43.28M derived: sum of 2 quarters · filed 2026-08-13 | -$65.43M 10-Q · filed 2025-11-14 | -$89.44M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||||
| 2025-06-30 | -$36.47M 10-Q · filed 2026-08-13 | -$58.79M 10-Q · filed 2026-08-13 | -$82.63M derived: sum of 3 quarters · filed 2026-08-13 | -$104.72M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||||
| 2025-03-31 | -$22.32M 10-Q · filed 2026-05-14 | -$46.15M derived: sum of 2 quarters · filed 2026-05-14 | -$68.25M derived: sum of 3 quarters · filed 2026-05-14 | -$96.03M derived: sum of 4 quarters · filed 2026-05-14 | |||||||||||||||
| 2024-12-31 | -$23.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$45.93M derived: sum of 2 quarters · filed 2026-03-31 | -$73.72M derived: sum of 3 quarters · filed 2026-03-31 | -$110.38M 10-K · filed 2026-03-31 | |||||||||||||||
| 2024-09-30 | -$22.09M 10-Q · filed 2025-11-14 | -$49.88M derived: sum of 2 quarters · filed 2025-11-14 | -$86.54M 10-Q · filed 2025-11-14 | -$106.06M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||||||
| 2024-06-30 | -$27.79M 10-Q · filed 2025-08-14 | -$64.35M 10-Q · filed 2025-08-14 | -$83.97M derived: sum of 3 quarters · filed 2025-08-14 | -$97.73M derived: sum of 4 quarters · filed 2025-08-14 | |||||||||||||||
| 2024-03-31 | -$36.57M 10-Q · filed 2025-05-15 | -$56.18M derived: sum of 2 quarters · filed 2025-05-15 | -$69.94M derived: sum of 3 quarters · filed 2025-05-15 | -$120.04M derived: sum of 4 quarters · filed 2025-05-15 | |||||||||||||||
| 2023-12-31 | -$19.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$33.37M derived: sum of 2 quarters · filed 2025-03-31 | -$83.48M derived: sum of 3 quarters · filed 2025-03-31 | -$142.34M 10-K · filed 2025-03-31 | |||||||||||||||
| 2023-09-30 | -$13.76M 10-Q · filed 2024-11-14 | -$63.86M derived: sum of 2 quarters · filed 2024-11-14 | -$122.73M 10-Q · filed 2024-11-14 | -$177.36M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||||
| 2023-06-30 | -$50.10M 10-Q · filed 2024-08-13 | -$108.97M 10-Q · filed 2024-08-13 | -$163.61M derived: sum of 3 quarters · filed 2024-08-13 | -$214.34M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||||
| 2023-03-31 | -$58.87M 10-Q · filed 2024-05-15 | -$113.50M derived: sum of 2 quarters · filed 2024-05-15 | -$164.24M derived: sum of 3 quarters · filed 2024-05-15 | -$215.16M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||||
| 2022-12-31 | -$54.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$105.37M derived: sum of 2 quarters · filed 2024-03-28 | -$156.29M derived: sum of 3 quarters · filed 2024-03-28 | -$203.56M 10-K · filed 2024-03-28 | |||||||||||||||
| 2022-09-30 | -$50.73M 10-Q · filed 2023-11-14 | -$101.66M derived: sum of 2 quarters · filed 2023-11-14 | -$148.93M 10-Q · filed 2023-11-14 | -$210.93M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$50.93M 10-Q · filed 2023-08-14 | -$98.20M 10-Q · filed 2023-08-14 | -$160.20M derived: sum of 3 quarters · filed 2023-08-14 | -$210.12M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||||
| 2022-03-31 | -$47.27M 10-Q · filed 2023-05-15 | -$109.27M derived: sum of 2 quarters · filed 2023-05-15 | -$159.19M derived: sum of 3 quarters · filed 2023-05-15 | -$202.05M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||||||
| 2021-12-31 | -$62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$111.92M derived: sum of 2 quarters · filed 2023-03-31 | -$154.78M derived: sum of 3 quarters · filed 2023-03-31 | -$188.54M 10-K · filed 2023-03-31 | |||||||||||||||
| 2021-09-30 | -$49.92M 10-Q · filed 2022-11-14 | -$92.78M derived: sum of 2 quarters · filed 2022-11-14 | -$126.54M 10-Q · filed 2022-11-14 | -$147.10M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||||
| 2021-06-30 | -$42.86M 10-Q · filed 2022-08-11 | -$72.87M 10-Q · filed 2022-08-11 | -$97.18M derived: sum of 3 quarters · filed 2022-08-11 | -$120.22M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||||||||
| 2021-03-31 | -$30.02M 10-Q · filed 2022-05-12 | -$54.32M derived: sum of 2 quarters · filed 2022-05-12 | -$77.36M derived: sum of 3 quarters · filed 2022-05-12 | -$102.76M derived: sum of 4 quarters · filed 2022-05-12 | |||||||||||||||
| 2020-12-31 | -$24.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$47.35M derived: sum of 2 quarters · filed 2022-03-28 | -$72.74M derived: sum of 3 quarters · filed 2022-03-28 | -$94.27M 10-K · filed 2022-03-28 | |||||||||||||||
| 2020-09-30 | -$23.04M 10-Q · filed 2021-11-15 | -$48.44M derived: sum of 2 quarters · filed 2021-11-15 | -$69.97M 10-Q · filed 2021-11-15 | -$100.35M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||||||
| 2020-06-30 | -$25.40M 10-Q · filed 2021-08-16 | -$46.92M 10-Q · filed 2021-08-16 | -$77.31M derived: sum of 3 quarters · filed 2021-08-16 | -$99.84M derived: sum of 4 quarters · filed 2021-08-16 | |||||||||||||||
| 2020-03-31 | -$21.53M 10-Q · filed 2021-05-17 | -$51.91M derived: sum of 2 quarters · filed 2021-05-17 | -$74.45M derived: sum of 3 quarters · filed 2021-05-17 | -$99.74M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||||||||
| 2019-12-31 | -$30.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | -$52.92M derived: sum of 2 quarters · filed 2021-04-09 | -$78.21M derived: sum of 3 quarters · filed 2021-04-09 | -$110.82M 10-K/A · filed 2021-04-09 | |||||||||||||||
| 2019-09-30 | -$22.54M 10-Q · filed 2020-11-09 | -$47.83M derived: sum of 2 quarters · filed 2020-11-09 | -$80.44M 10-Q · filed 2020-11-09 | -$121.65M derived: sum of 4 quarters · filed 2020-11-09 | |||||||||||||||
| 2019-06-30 | -$25.29M 10-Q · filed 2020-08-10 | -$57.90M 10-Q · filed 2020-08-10 | -$99.11M derived: sum of 3 quarters · filed 2020-08-10 | -$127.32M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||||||
| 2019-03-31 | -$32.61M 10-Q · filed 2020-05-11 | -$73.82M derived: sum of 2 quarters · filed 2020-05-11 | -$102.03M derived: sum of 3 quarters · filed 2020-05-11 | -$127.42M derived: sum of 4 quarters · filed 2020-05-11 | |||||||||||||||
| 2018-12-31 | -$41.21M 10-K · filed 2019-03-18 | -$69.42M derived: sum of 2 quarters · filed 2019-11-12 | -$94.82M derived: sum of 3 quarters · filed 2019-11-12 | -$120.00M 10-K · filed 2020-03-16 | |||||||||||||||
| 2018-09-30 | -$28.20M 10-Q · filed 2019-11-12 | -$24.89M 10-Q · filed 2018-11-09 | -$53.60M derived: sum of 2 quarters · filed 2019-11-12 | -$87.78M 10-Q · filed 2019-11-12 | -$84.97M 10-Q · filed 2018-11-09 | -$118.40M derived: sum of 4 quarters · filed 2019-11-12 | |||||||||||||
| 2018-06-30 | -$25.40M 10-Q · filed 2019-08-09 | -$24.60M 10-Q · filed 2018-08-09 | -$59.57M 10-Q · filed 2019-08-09 | -$60.08M 10-Q · filed 2018-08-09 | -$90.19M derived: sum of 3 quarters · filed 2019-08-09 | -$121.99M derived: sum of 4 quarters · filed 2019-08-09 | |||||||||||||
| 2018-03-31 | -$34.17M 10-Q · filed 2019-05-10 | -$35.49M 10-Q · filed 2018-05-10 | -$64.79M derived: sum of 2 quarters · filed 2019-05-10 | -$96.59M derived: sum of 3 quarters · filed 2019-05-10 | -$122.09M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||||
| 2017-12-31 | -$30.62M 10-K · filed 2019-03-18 | -$73.15M 10-K · filed 2018-03-16 | -$62.42M derived: sum of 2 quarters · filed 2019-03-18 | -$87.92M derived: sum of 3 quarters · filed 2019-03-18 | -$89.80M 10-K · filed 2019-03-18 | -$101.21M 10-K · filed 2018-03-16 | |||||||||||||
| 2017-09-30 | -$31.80M 10-K · filed 2019-03-18 | -$32.60M 10-Q · filed 2017-11-09 | -$57.29M derived: sum of 2 quarters · filed 2019-03-18 | -$73.37M 10-Q · filed 2018-11-09 | -$108.64M derived: sum of 4 quarters · filed 2019-03-18 | ||||||||||||||
| 2017-06-30 | -$25.50M 10-K · filed 2019-03-18 | -$23.19M 10-Q · filed 2017-08-09 | -$40.77M 10-Q · filed 2018-08-09 | -$76.84M derived: sum of 3 quarters · filed 2019-03-18 | -$94.02M derived: sum of 4 quarters · filed 2019-03-18 | ||||||||||||||
| 2017-03-31 | -$19.13M 10-K · filed 2019-03-18 | -$17.58M 10-Q · filed 2017-05-10 | -$51.34M derived: sum of 2 quarters · filed 2019-03-18 | -$68.52M derived: sum of 3 quarters · filed 2019-03-18 | -$85.56M derived: sum of 4 quarters · filed 2019-03-18 | ||||||||||||||
| 2016-12-31 | -$32.22M 10-K · filed 2018-03-16 | -$49.40M derived: sum of 2 quarters · filed 2018-03-16 | -$66.44M derived: sum of 3 quarters · filed 2018-03-16 | -$65.71M 10-K · filed 2018-03-16 | |||||||||||||||
| 2016-09-30 | -$17.18M 10-K · filed 2018-03-16 | -$16.25M 10-Q · filed 2016-11-09 | -$34.22M derived: sum of 2 quarters · filed 2018-03-16 | -$46.47M 10-Q · filed 2017-11-09 | -$62.76M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||||||
| 2016-06-30 | -$17.04M 10-K · filed 2018-03-16 | -$15.14M 10-Q · filed 2016-08-09 | -$30.23M 10-Q · filed 2017-08-09 | -$45.58M derived: sum of 3 quarters · filed 2018-03-16 | -$63.67M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||||||
| 2016-03-31 | -$15.57M 10-K · filed 2018-03-16 | -$15.09M 10-Q · filed 2016-05-10 | -$28.54M derived: sum of 2 quarters · filed 2018-03-16 | -$46.63M derived: sum of 3 quarters · filed 2018-03-16 | -$54.39M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||||||
| 2015-12-31 | -$12.96M 10-K · filed 2017-03-16 | -$31.06M derived: sum of 2 quarters · filed 2017-03-16 | -$38.82M derived: sum of 3 quarters · filed 2017-03-16 | -$50.53M 10-K · filed 2018-03-16 | |||||||||||||||
| 2015-09-30 | -$18.10M 10-K · filed 2017-03-16 | -$18.07M 10-Q · filed 2015-11-09 | -$25.86M derived: sum of 2 quarters · filed 2017-03-16 | -$37.91M 10-Q · filed 2016-11-09 | -$43.39M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-06-30 | -$7.76M 10-K · filed 2017-03-16 | -$19.83M 10-Q · filed 2016-08-09 | -$25.29M derived: sum of 3 quarters · filed 2017-03-16 | -$29.64M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||||
| 2015-03-31 | -$12.57M 10-K · filed 2017-03-16 | -$12.07M 10-Q · filed 2015-05-11 | -$17.53M derived: sum of 2 quarters · filed 2017-03-16 | -$21.88M derived: sum of 3 quarters · filed 2017-03-16 | -$26.64M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2014-12-31 | -$4.96M 10-K · filed 2016-03-15 | -$9.31M derived: sum of 2 quarters · filed 2016-03-15 | -$14.07M derived: sum of 3 quarters · filed 2016-03-15 | -$20.65M 10-K · filed 2017-03-16 | |||||||||||||||
| 2014-09-30 | -$4.35M 10-K · filed 2016-03-15 | -$9.11M derived: sum of 2 quarters · filed 2016-03-15 | -$15.69M 10-Q · filed 2015-11-09 | -$25.21M derived: sum of 4 quarters · filed 2016-03-15 | |||||||||||||||
| 2014-06-30 | -$4.76M 10-K · filed 2016-03-15 | -$11.35M 10-Q · filed 2015-08-10 | -$20.87M derived: sum of 3 quarters · filed 2016-03-15 | -$28.37M derived: sum of 4 quarters · filed 2016-03-15 | |||||||||||||||
| 2014-03-31 | -$6.58M 10-K · filed 2016-03-15 | -$16.11M derived: sum of 2 quarters · filed 2016-03-15 | -$23.61M derived: sum of 3 quarters · filed 2016-03-15 | -$33.90M derived: sum of 4 quarters · filed 2016-03-15 | -$122.40M 10-Q · filed 2014-05-12 | ||||||||||||||
| 2013-12-31 | -$9.52M 10-K · filed 2015-03-16 | -$17.03M derived: sum of 2 quarters · filed 2015-03-16 | -$27.32M derived: sum of 3 quarters · filed 2015-03-16 | -$35.78M 10-K · filed 2016-03-15 | -$115.82M 10-K · filed 2014-03-14 | ||||||||||||||
| 2013-09-30 | -$7.50M 10-K · filed 2015-03-16 | -$17.80M derived: sum of 2 quarters · filed 2015-03-16 | -$26.26M 10-Q · filed 2014-11-06 | -$34.55M derived: sum of 4 quarters · filed 2015-03-16 | -$106.29M 10-Q · filed 2013-11-01 | ||||||||||||||
| 2013-06-30 | -$10.29M 10-K · filed 2015-03-16 | -$18.75M 10-Q · filed 2014-08-11 | -$27.05M derived: sum of 3 quarters · filed 2015-03-16 | -$32.88M derived: sum of 4 quarters · filed 2015-03-16 | -$98.79M 10-Q · filed 2013-08-05 | ||||||||||||||
| 2013-03-31 | -$8.46M 10-K · filed 2015-03-16 | -$16.76M derived: sum of 2 quarters · filed 2015-03-16 | -$22.59M derived: sum of 3 quarters · filed 2015-03-16 | -$29.05M derived: sum of 4 quarters · filed 2015-03-16 | -$88.50M 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | -$8.30M 10-K · filed 2014-03-14 | -$8.23M 10-K · filed 2013-03-18 | -$14.13M derived: sum of 2 quarters · filed 2014-03-14 | -$20.59M derived: sum of 3 quarters · filed 2014-03-14 | -$27.18M 10-K · filed 2015-03-16 | -$80.04M 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | -$5.83M 10-K · filed 2014-03-14 | -$12.30M derived: sum of 2 quarters · filed 2014-03-14 | -$18.88M 10-Q · filed 2013-11-01 | -$24.11M derived: sum of 4 quarters · filed 2014-03-14 | -$71.74M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | -$6.46M 10-K · filed 2014-03-14 | -$13.05M 10-Q · filed 2013-08-05 | -$18.28M derived: sum of 3 quarters · filed 2014-03-14 | -$21.81M derived: sum of 4 quarters · filed 2014-03-14 | -$65.91M 10-Q · filed 2012-08-08 | ||||||||||||||
| 2012-03-31 | -$6.58M 10-K · filed 2014-03-14 | -$11.81M derived: sum of 2 quarters · filed 2014-03-14 | -$15.34M derived: sum of 3 quarters · filed 2014-03-14 | -$19.08M derived: sum of 4 quarters · filed 2014-03-14 | -$59.44M 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | -$5.23M 10-K · filed 2013-03-18 | -$8.76M derived: sum of 2 quarters · filed 2013-03-18 | -$12.50M derived: sum of 3 quarters · filed 2013-03-18 | -$35.04M 10-K · filed 2014-03-14 | -$52.86M 10-K · filed 2012-03-29 | ||||||||||||||
| 2011-09-30 | -$3.53M 10-K · filed 2013-03-18 | -$7.27M derived: sum of 2 quarters · filed 2013-03-18 | -$29.81M 10-Q · filed 2012-11-14 | -$32.20M derived: sum of 4 quarters · filed 2013-03-18 | -$47.63M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | -$3.74M 10-K · filed 2013-03-18 | -$26.28M 10-Q · filed 2012-08-08 | -$28.67M derived: sum of 3 quarters · filed 2013-03-18 | -$30.75M derived: sum of 4 quarters · filed 2013-03-18 | |||||||||||||||
| 2011-03-31 | -$22.55M 10-K · filed 2013-03-18 | -$24.93M derived: sum of 2 quarters · filed 2013-03-18 | -$27.02M derived: sum of 3 quarters · filed 2013-03-18 | ||||||||||||||||
| 2010-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$4.47M derived: sum of 2 quarters · filed 2013-03-18 | -$9.24M 10-K · filed 2013-03-18 | ||||||||||||||||
| 2010-09-30 | -$2.08M 10-Q · filed 2011-11-14 | -$6.85M 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2009-12-31 | -$2.61M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |